Related Experiment Video
Updated: May 3, 2026

Tri-layered Electrospinning to Mimic Native Arterial Architecture using Polycaprolactone, Elastin, and Collagen: A Preliminary Study
Published on: January 4, 2011
Polycaprolactone (PCL)-Gelatin Electrospun Meshes for Accelerated Gastric Wound Healing
Sara F C Guerreiro1, Filipa Leal2, Anabela G Dias3
1CDRSP - Centro para o Desenvolvimento Rápido e Sustentado do Produto, Politécnico de Leiria, R. de Portugal, Leiria 2430-028, Portugal; Medical Physics, Radiobiology and Radiation Protection Group, IPO Porto Research Center (CI-IPO), Portuguese Oncology Institute of Porto (IPO/Porto)/Porto Comprehensive Cancer Centre (Porto.CCC) & RISE@CI-IPO (Health Research Network), R. Dr. António Bernardino de Almeida, Porto 4200-072, Portugal; i3S - Instituto de Investigação e Inovação em Saúde, Universidade do Porto, R. Alfredo Allen 208, Porto 4200-135, Portugal; FEUP - Faculdade de Engenharia da Universidade do Porto, R. Dr. Roberto Frias, s/n, Porto 4200-135, Portugal.
Abstract:
Gastric wound healing constitutes a complex challenge, even in the context of superficial wounds, due to the harsh stomach environment, characterized by high pH variability and dynamic enzyme concentrations. Therefore, effective healing depends on robust mechanical support and adequate biochemical cues to drive cell growth and proliferation. Electrospun-based dressings may offer a solution to these problems by providing physical support that mimics native extracellular matrix. In this study, electrospun dressings composed of a blend of polycaprolactone (PCL) and gelatin (Gel) were proposed for the first time for gastric application by tuning the relative PCL:Gel ratios (75:25, 50:50 and 25:75) to optimize both their retention capacity and cellular interaction. PCL/Gel dressings, in a proportion of 75:25, showed to have efficient mucoadhesion (ultimate stress of 1.8 MPa) when tested in ex vivo porcine samples. They were also stable in simulated gastric fluid for 14 days, a period compatible with the treatment window. Moreover, the non-cytotoxic biological response (>90 %) of the dressings was favorably validated in mouse fibroblast L929 cell line. Cell morphology, metabolic activity, cell viability and proliferative capacity were assessed using human specific gastric cell lines, including normal stomach fibroblasts (NST-20) and gastric adenocarcinoma (AGS). Overall, PCL/Gel dressings of 75:25 increased the proliferation rate of NST20 and AGS cells after 3 and 7 days in culture, respectively, with significant expression of proliferation marker Ki-67 protein.

